阿莫西林混悬液短缺期间儿科急诊使用头孢氨苄的经验
研究为在加拿大2022年末阿莫西林混悬液严重短缺背景下开展的回顾性队列分析,纳入2020年7月至2023年6月儿科急诊出院时开具抗生素的急性中耳炎、社区获得性肺炎和咽炎患儿,通过ICD-10诊断编码和EPIC电子健康记录识别病例。共7387次合格就诊,短缺期间头孢氨苄与阿莫西林-克拉维酸是最常用的阿莫西林替代药物。比较分析显示,不同抗生素方案在治疗后21天内的再就诊率或不良事件率无统计学显著差异。作者结论认为,头孢氨苄是阿莫西林短缺期间上述三种疾病的可选替代药物,并因其抗菌谱较窄可能带来抗菌药物管理方面的获益。
要点
- 研究纳入7387次儿科急诊就诊,比较急性中耳炎、社区获得性肺炎和咽炎出院时不同抗生素处方的结局。
- 短缺期间头孢氨苄与阿莫西林-克拉维酸是最常用的阿莫西林替代药物。
- 不同抗生素方案在3天再就诊(潜在治疗失败)和21天再就诊(潜在不良事件)上均无统计学显著差异。
- 作者认为头孢氨苄是阿莫西林短缺期间急性中耳炎、社区获得性肺炎和咽炎的可选替代药物,并可能因抗菌谱较窄而有利于抗菌药物管理。
适用人群与场景
- 2020年7月至2023年6月在儿科急诊被诊断为急性中耳炎、社区获得性肺炎或咽炎,并在出院时获得抗生素处方的儿科患者。
- 研究场景为急诊出院带药,病例通过ICD-10诊断编码识别,数据来自EPIC电子健康记录系统。
研究设计与关键结果
- 研究类型为回顾性队列分析,共纳入7387次合格儿科急诊就诊,比较急性中耳炎、社区获得性肺炎和咽炎患儿出院时使用头孢氨苄与其他抗生素的结局。
- 短缺期间头孢氨苄与阿莫西林-克拉维酸是最常用的阿莫西林替代药物。
- 以首诊后3天内再就诊作为潜在治疗失败的指标、21天内再就诊作为潜在不良事件的指标,不同抗生素方案之间再就诊率或不良事件率均无统计学显著差异。
证据类型、等级与局限
- 证据类型为回顾性队列分析;原文未报告证据等级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在阿莫西林短缺期间,头孢氨苄可作为儿科急性中耳炎、社区获得性肺炎和咽炎的合适替代药物,并可能因其抗菌谱较窄而带来抗菌药物管理方面的获益。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: During a significant shortage of amoxicillin suspension in Canada in late 2022, local guidelines recommended cephalexin as an alternative with restricted use of amoxicillin-clavulanate (AC). The aim of the study was to determine outcomes of patients with a diagnosis of acute otitis media (AOM), community acquired pneumonia (AOM) and pharyngitis who were prescribed cephalexin compared to other antibiotics in the emergency department (ED).
MATERIALS AND METHODS: We conducted a retrospective cohort analysis of pediatric patients diagnosed with AOM, CAP, and pharyngitis who received antibiotic prescriptions upon discharge from the ED between July 2020 and June 2023. Cases were identified using ICD-10 diagnostic codes, and data were extracted from the EPIC™ electronic health record system. We compared return visits within 3 days and 21 days of the index encounter as measures of potential treatment failure and adverse events, respectively.
RESULTS: Among 7387 eligible patient encounters, cephalexin and AC emerged as the most frequently prescribed alternatives to amoxicillin during the shortage period. Comparative analysis revealed no statistically significant differences in the rates of return visits or adverse events within 21 days post-treatment initiation across the different antibiotic regimens.
CONCLUSIONS: Cephalexin represents a suitable alternative for AOM, CAP, and pharyngitis during an amoxicillin shortage, with potential antimicrobial stewardship benefits due to its narrower spectrum.
参考来源
- Alquarshi W, O'Donnell R, Eckbo E, et al. Cephalexin use in a pediatric emergency department during the shortage of amoxicillin suspension. Am J Emerg Med. 2025. PMID: 41075723. doi:10.1016/j.ajem.2025.10.006
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。